Abstract
Nine months after the first reports describing a novel corona virus (Severe Acute Respiratory Syndrome coronavirus 2, SARS-CoV-2) causing severe disease in humans (coronavirus Disease 2019, COVID-19) [1], and with over 25 million infected individuals worldwide, questions regarding the clinical relevance and public health implications of SARS-CoV-2 viral shedding remain unanswered. In this article of EBioMedicine, Dr. Changwen Ke and colleagues report that, in a subset of COVID-19 patients, SARS-CoV-2 nucleic acid can be detected intermittently in nasopharyngeal specimens despite symptom resolution [2].
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have